Figure 3.
Novel pharmacogenetic association. Participants with the PAI-1 G5 variant appeared to have a better systolic blood pressure response to treatment with an angiotensin converting enzyme inhibitor (p = 0.045)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.